01 · Control
The provider remains in control
Providers define what they offer, for which purposes, under which conditions and which results may leave their environment.
EDGE/DM ecosystem
A governed data space for MedTech innovation
An environment where providers, manufacturers, developers, clinical organisations and technology partners turn data, models and capabilities into Data Products that can be used under clear conditions.
Value proposition
Built for use, not data accumulation
EDGE/DM connects supply and demand around concrete resources, preserving provider control and introducing a reviewable process before access or execution.
02 · Purpose
Access linked to a stated purpose
Requests are reviewed against the declared purpose, eligibility and the specific conditions of each Data Product.
03 · Capability
Data and services in one catalogue
The space can bring together datasets, inference services, benchmarks, secure workflows and reusable evidence.
04 · Trust
Evidence and traceability
Provenance, versions, restrictions, executions and results remain associated with the product and its context of use.
Data Product lifecycle
From asset to governed use
The proposition does not end when a catalogue entry is published. EDGE/DM structures the journey required for an asset to be discovered and used in a controlled way.
- OnboardA participant contributes a dataset, model, service, benchmark or technical capability.
- ProductiseContent, quality, scope, evidence, restrictions and access model are documented.
- Discover and requestUsers review the public offer and submit a request linked to a stated purpose.
- Access or executeUse follows the agreed mechanism: controlled access, API, runtime or execution next to the data.
- RecordConditions, versions, results and traceability are retained to support review and trust.
Current catalogue
Initial Data Products in the pilot data space
These products illustrate different forms of value: validation against reference, delivery of clinical capabilities and stronger confidence in results.
Lateral Flow Reader Validation & Robustness Benchmark
Evaluates LFT readers, applications or algorithms against governed images and reference values, supported by the SmartDX ground-truth dataset.
View product →Early sepsis prediction
A time-series service for exploring inference over clinical signals under a defined access and usage framework.
View product →Malaria microscopy
An inference capability for microscopy images, presented with its scope, available evidence and usage boundaries.
View product →AI interpretability and traceability
A service that links AI results to explanations, records and evidence supporting review, audit and responsible use.
View product →Ecosystem
A common infrastructure for different roles
Value emerges when participants can collaborate without giving up their responsibilities or control over their assets.
Data and ground-truth providers
MedTech manufacturers and developers
AI and interoperability partners
Governance and evaluation roles
Participation
Find your pathway into EDGE/DM
Each organisation can enter with a different role and evolve from an initial conversation to publishing or using a Data Product.
I want to contribute an asset
Explore how to describe and publish data, ground truth, models, services or capabilities while preserving conditions and control.
Value for providers →I want to use a product
Review the public catalogue, including scope, evidence, availability and access model, before requesting participation.
Explore Data Products →I want to contribute technology
Collaborate on inference, validation, interoperability, secure execution, analytics or traceability.
AI collaboration →I want to understand the rules
Review roles, access decisions, obligations, usage boundaries and trust mechanisms.
Governance and trust →Documentation
Go deeper into the EDGE/DM model
Public documentation explains the data-space proposition, participation pathways, governance, technical foundations and value models.